LAG3 and gastric cancer: In another study, combinatorial Tim-3/Lag-3/PD-1 blockade significantly improved antitumor immunity in gastric cancer cell-T cell coculture models, suggesting the therapeutic potential of combinatorial therapy in gastric cancer patients (66).